SCHEMBL23624939

SCHEMBL23624939

N=S1(=O)CCN(c2ccc(N)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.55
ALDH1A1 P00352 9/20 0.55
GFER P55789 6/20 0.55
GAA P10253 5/20 0.55
KDM4E B2RXH2 4/20 0.55
KMT2A Q03164 2/20 0.55
ADRA2C P18825 2/20 0.55
PTK2B Q14289 1/20 0.55
ESR2 Q92731 1/20 0.55
HTT P42858 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
MEN1 O00255 1/20 0.52
NPC1 O15118 1/20 0.52
USP2 O75604 1/20 0.52
TP53 P04637 1/20 0.52
POLB P06746 1/20 0.52
THRB P10828 1/20 0.52
ALOX15 P16050 1/20 0.52
RECQL P46063 1/20 0.52
RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175496 0.84 KDM4E (0.59) MAPTALDH1A1GFERGAAKDM4E
SCHEMBL16635950 0.81 AKR1C3 (0.44) MAPTALDH1A1GAAKDM4EKMT2A
SCHEMBL6151120 0.76 MAPT (0.77) MAPTALDH1A1GFERGAAKDM4E
SCHEMBL23347931 0.76 MAPT (0.77) MAPTALDH1A1GFERGAAKDM4E
SCHEMBL7043679 0.76 MAPT (0.77) MAPTALDH1A1GFERGAAKDM4E
SCHEMBL175497 0.76 MAPT (0.59) MAPTALDH1A1GFERGAAKDM4E
SCHEMBL24884606 0.76 MAPT (0.64) MAPTALDH1A1GFERGAAKDM4E
SCHEMBL23619109 0.74 GRIN2D (0.47) MAPTALDH1A1KDM4ENPSR1LMNA
SCHEMBL23611855 0.73 ALDH1A1 (0.43) MAPTALDH1A1GAAKDM4EKMT2A
SCHEMBL23611900 0.73 GFER (0.47) MAPTALDH1A1GFERGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219960-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. (CN) 2023-07-13 US disclosed
WO-2021138392-A1 AMINOPYRIMIDINE COMPOUNDS TYRA BIOSCIENCES, INC. (US) 2021-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219960-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 SYK, KDR, FLT1 MAPT 4275/4885ALDH1A1 2164/4885GFER 3248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.